Fuller & Thaler Asset Management Has Lowered Its Brink’s Co (BCO) Holding; Ardsley Advisory Partners Has Decreased Lilly Eli & Co (LLY) Position By $410,000

December 7, 2017 - By wolcottdaily

Fuller & Thaler Asset Management Inc decreased Brink’s Co (BCO) stake by 30.65% reported in 2017Q2 SEC filing. Fuller & Thaler Asset Management Inc sold 460,122 shares as Brink’s Co (BCO)’s stock rose 12.51%. The Fuller & Thaler Asset Management Inc holds 1.04M shares with $69.74M value, down from 1.50 million last quarter. Brink’s Co now has $4.05B valuation. The stock increased 1.77% or $1.4 during the last trading session, reaching $80.3. About 232,756 shares traded. The Brink's Company (NYSE:BCO) has risen 110.61% since December 7, 2016 and is uptrending. It has outperformed by 93.91% the S&P500.

Ardsley Advisory Partners decreased Lilly Eli & Co (LLY) stake by 66.67% reported in 2017Q2 SEC filing. Ardsley Advisory Partners sold 5,000 shares as Lilly Eli & Co (LLY)’s stock declined 3.22%. The Ardsley Advisory Partners holds 2,500 shares with $206,000 value, down from 7,500 last quarter. Lilly Eli & Co now has $89.35 billion valuation. The stock decreased 0.86% or $0.74 during the last trading session, reaching $85.32. About 3.13 million shares traded. Eli Lilly and Company (NYSE:LLY) has risen 4.70% since December 7, 2016 and is uptrending. It has underperformed by 12.00% the S&P500.

Ardsley Advisory Partners increased Spdr Series Trust (XBI) stake by 56,500 shares to 276,000 valued at $21.30M in 2017Q2. It also upped Canadian Solar Inc (NASDAQ:CSIQ) stake by 170,500 shares and now owns 568,000 shares. American Superconductor Corp was raised too.

Among 20 analysts covering Eli Lilly and Company (NYSE:LLY), 12 have Buy rating, 1 Sell and 7 Hold. Therefore 60% are positive. Eli Lilly and Company had 86 analyst reports since July 23, 2015 according to SRatingsIntel. As per Friday, December 18, the company rating was initiated by Atlantic Securities. The stock of Eli Lilly and Company (NYSE:LLY) earned “Underperform” rating by BMO Capital Markets on Tuesday, October 10. The firm earned “Outperform” rating on Saturday, August 22 by Cowen & Co. Credit Suisse upgraded the stock to “Outperform” rating in Tuesday, December 8 report. The company was maintained on Monday, May 2 by Leerink Swann. On Friday, October 13 the stock rating was maintained by Barclays Capital with “Overweight”. The rating was maintained by Jefferies on Tuesday, March 15 with “Buy”. As per Tuesday, August 2, the company rating was maintained by Argus Research. Piper Jaffray maintained Eli Lilly and Company (NYSE:LLY) rating on Thursday, October 12. Piper Jaffray has “Buy” rating and $105.0 target. Jefferies maintained the shares of LLY in report on Friday, September 15 with “Buy” rating.

Investors sentiment decreased to 0.9 in Q2 2017. Its down 0.08, from 0.98 in 2017Q1. It dived, as 61 investors sold LLY shares while 400 reduced holdings. 95 funds opened positions while 320 raised stakes. 823.00 million shares or 0.09% more from 822.25 million shares in 2017Q1 were reported. Howland Cap Management Ltd Llc reported 4,872 shares. Commonwealth Of Pennsylvania Public School Empls Retrmt, Pennsylvania-based fund reported 72,138 shares. River & Mercantile Asset Mgmt Llp reported 66,500 shares. Patten Group Inc invested in 0.05% or 1,500 shares. Fdx Advsr owns 89,441 shares. Central Comml Bank & holds 1,269 shares. Connors Investor reported 0.75% of its portfolio in Eli Lilly and Company (NYSE:LLY). Fred Alger invested in 62,975 shares or 0.02% of the stock. Commonwealth Bank Of Australia reported 36,031 shares. Timber Creek Capital Management Limited Liability Com has 56,611 shares. The Delaware-based Dupont Mgmt has invested 0.08% in Eli Lilly and Company (NYSE:LLY). Shelton Capital Mngmt reported 0.06% stake. Capital Sarl accumulated 39,470 shares. First Allied Advisory Ser Inc accumulated 0.1% or 27,616 shares. Retail Bank Hapoalim Bm invested in 0.08% or 4,255 shares.

Since June 9, 2017, it had 0 insider buys, and 1 sale for $153,482 activity. 22,833 shares were sold by Harrington Michael J, worth $1.83 million on Friday, June 9. 1,900 shares valued at $153,482 were sold by Barnes Melissa S on Monday, June 12.

Analysts await Eli Lilly and Company (NYSE:LLY) to report earnings on January, 30. They expect $1.08 EPS, up 13.68% or $0.13 from last year’s $0.95 per share. LLY’s profit will be $1.13B for 19.75 P/E if the $1.08 EPS becomes a reality. After $1.05 actual EPS reported by Eli Lilly and Company for the previous quarter, Wall Street now forecasts 2.86% EPS growth.

Analysts await The Brink's Company (NYSE:BCO) to report earnings on February, 14. They expect $1.02 EPS, up 17.24% or $0.15 from last year’s $0.87 per share. BCO’s profit will be $51.50 million for 19.68 P/E if the $1.02 EPS becomes a reality. After $0.83 actual EPS reported by The Brink's Company for the previous quarter, Wall Street now forecasts 22.89% EPS growth.

Fuller & Thaler Asset Management Inc increased Celanese Corp (NYSE:CE) stake by 6,898 shares to 1.59 million valued at $151.40 million in 2017Q2. It also upped Bob Evans Farms Inc (NASDAQ:BOBE) stake by 32,900 shares and now owns 55,000 shares. Trinseo Sa (NYSE:TSE) was raised too.

Among 3 analysts covering Brink’s Company (NYSE:BCO), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Brink’s Company had 10 analyst reports since August 4, 2015 according to SRatingsIntel. Imperial Capital downgraded The Brink's Company (NYSE:BCO) rating on Friday, October 28. Imperial Capital has “In-Line” rating and $42 target. Macquarie Research maintained the stock with “Neutral” rating in Friday, September 16 report. The firm earned “Buy” rating on Wednesday, August 9 by Imperial Capital. As per Tuesday, August 4, the company rating was downgraded by Zacks. Imperial Capital maintained it with “In-Line” rating and $52 target in Thursday, February 9 report. The company was maintained on Friday, May 20 by Imperial Capital. The firm has “In-Line” rating by Imperial Capital given on Thursday, May 25. The rating was maintained by SunTrust on Thursday, September 28 with “Buy”. Macquarie Research upgraded the stock to “Outperform” rating in Monday, December 12 report. The stock of The Brink's Company (NYSE:BCO) has “Buy” rating given on Tuesday, February 28 by SunTrust.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>